|drug2376||PD-1 blocking antibody+standard treatment Wiki||1.00|
|drug805||Clinical diagnosis of COVID-19 by a health care professional Wiki||1.00|
|drug4124||standard treatment Wiki||1.00|
There is one clinical trial.
The International Registry of Coronavirus Exposure in Pregnancy (IRCEP) is a prospective cohort study of pregnant and recently pregnant women who have been tested for SARS-CoV-2 (regardless of the result) or have been clinically diagnosed with COVID-19 by a health care professional. Data from the IRCEP will be used to evaluate the impact of COVID-19 on pregnancy and birth outcomes.
Description: Miscarriage (or spontaneous abortion), Elective termination, Stillbirth, Preterm deliveryMeasure: Pregnancy outcomes Time: 1 year
Description: Major structural defects, neonatal death, Admission into the Neonatal Intensive Care Unit, Maternal obstetric complications, Post-partum healthMeasure: Birth outcomes Time: Birth to 90 days post-partum
Description: Head circumference at birth in centimetersMeasure: Birth outcomes Time: Birth to 90 days post-partum
Description: Length at birth in centimetersMeasure: Birth outcomes Time: Birth to 90 days post-partum
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports